Episode
E117: Inebilizumab for IgG4-RD (MITIGATE)
- Published
- Dec 3, 2024
- Duration seconds
- 775
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e117-inebilizumab-for-igg4-rd-mitigate/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e117-inebilizumab-for-igg4-rd-mitigate.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
New RCT in a new disease with a new drug! But is it as shiny as one would hope? Interesting discussion today about what a trial means, how it will affect practice, and how we could do better as a field. Happy holidays everyone!